Tolvaptan, a Selective Oral Vasopressin V -Receptor Antagonist, for Hyponatremia

Tolvaptan, a Selective Oral Vasopressin V -Receptor Antagonist, for Hyponatremia

瀏覽:498
日期:2024-08-22
Tolvaptan for Hyponatremia n engl j med 355;20 www.nejm.org november 16, 2006 2103 244 Patients underwent screening 205 Met inclusion criteria 102 Assigned to tolvaptan 15 mg daily 103 Assigned to placebo 15 mg daily Increased to 30 mg or 60 mg, if ......看更多